Want to see KMTS full AI Analyst Report?
Total Valuation
Kestra Medical Technologies Ltd. has a market cap or net worth of $1.70B. The enterprise value is $1.21K.
Market Cap$1.70B
Enterprise Value$1.21K
Share Statistics
Kestra Medical Technologies Ltd. has 59,561,794 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding59,561,794
Owned by Insiders1.61%
Owned by Institutions59.39%
Financial Efficiency
Kestra Medical Technologies Ltd.’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -43.73%.
Return on Equity (ROE)-0.51
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-43.73%
Return on Capital Employed (ROCE)-0.44
Revenue Per Employee214.73K
Profits Per Employee-297.09K
Employee Count443
Asset Turnover0.27
Inventory Turnover6.90
Valuation Ratios
The current PE Ratio of Kestra Medical Technologies Ltd. is ―. Kestra Medical Technologies Ltd.’s PEG ratio is 0.16.
PE Ratio―
PS Ratio12.72
PB Ratio4.66
Price to Fair Value4.66
Price to FCF-10.38
Price to Operating Cash Flow-18.89
PEG Ratio0.16
Income Statement
In the last 12 months, Kestra Medical Technologies Ltd. had revenue of 95.13M and earned -131.61M in profits. Earnings per share was -2.43.
Revenue95.13M
Gross Profit48.86M
Operating Income-134.74M
Pretax Income-131.32M
Net Income-131.61M
EBITDA-150.04M
Earnings Per Share (EPS)-2.43
Cash Flow
In the last 12 months, operating cash flow was -87.72M and capital expenditures -35.06M, giving a free cash flow of -122.78M billion.
Operating Cash Flow-87.72M
Free Cash Flow-122.78M
Free Cash Flow per Share-2.06
Dividends & Yields
Kestra Medical Technologies Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.29
52-Week Price Change16.13%
50-Day Moving Average25.50
200-Day Moving Average23.59
Relative Strength Index (RSI)64.53
Average Volume (3m)347.65K
Important Dates
Kestra Medical Technologies Ltd. upcoming earnings date is Dec 10, 2026, After Close (Confirmed).
Last Earnings DateSep 14, 2026
Next Earnings DateDec 10, 2026
Ex-Dividend Date―
Financial Position
Kestra Medical Technologies Ltd. as a current ratio of 4.41, with Debt / Equity ratio of 34.38%
Current Ratio4.41
Quick Ratio4.28
Debt to Market Cap0.04
Net Debt to EBITDA0.35
Interest Coverage Ratio-17.85
Taxes
In the past 12 months, Kestra Medical Technologies Ltd. has paid 294.00K in taxes.
Income Tax294.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Kestra Medical Technologies Ltd. EV to EBITDA ratio is -7.71, with an EV/FCF ratio of -9.92.
EV to Sales12.16
EV to EBITDA-7.71
EV to Free Cash Flow-9.92
EV to Operating Cash Flow-14.16
Balance Sheet
Kestra Medical Technologies Ltd. has $198.91M in cash and marketable securities with $76.45M in debt, giving a net cash position of $122.47M billion.
Cash & Marketable Securities$198.91M
Total Debt$76.45M
Net Cash$122.47M
Net Cash Per Share$2.06
Tangible Book Value Per Share$4.45
Margins
Gross margin is 53.89%, with operating margin of -141.64%, and net profit margin of -138.35%.
Gross Margin53.89%
Operating Margin-141.64%
Pretax Margin-138.04%
Net Profit Margin-138.35%
EBITDA Margin-157.72%
EBIT Margin-153.10%
Analyst Forecast
The average price target for Kestra Medical Technologies Ltd. is $30.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$30.00
Price Target Upside17.46% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast60.72%
EPS Growth Forecast-5.66%